Union Health Minister J P Nadda on Saturday launched the Indian
Council of Medical Research’s (ICMR) flagship initiative ‘Medical Innovations
Patent Mitra’ to enhance India's healthcare innovation
ecosystem.
The initiative aims at providing end-to-end
guidance and handholding support to innovators for patent filings and
technology transfer of medical innovations to industry.The initiative was
launched at the International Symposium on Health Technology Assessment
(ISHTA).
This program,
developed under the guidance of NITI Aayog and in
partnership with the Department of Pharmaceuticals (DoP), is supported by the
Department for Promotion of Industry and Internal Trade (DPIIT).
The launch was followed by a panel discussion that
brought together bureaucrats, industry leaders, investors, and public health
experts to explore the challenges, opportunities, and strategies for enhancing
patent filing and technology transfer in the context of translational research
and medical innovation.
Nadda said,
"Medical innovation Patent Mitra is a testament of ICMR's commitment to
advancing medical innovation. With the launch of this initiative, our country
is taking significant lead towards supporting our innovators.” “This platform will ensure that the groundbreaking
work done by our scientists and researchers is protected through patents and
made available to the public through seamless technology transfer. This visionary effort propels India
towards attaining the goal of Viksit Bharat," the Union minister said.
Dr V K Paul, Member (Health) NITI Aayog, emphasised
on the significance of the Patent Mitra initiative in directly contributing to
the goals of Ayushman Bharat, ensuring that innovative technologies developed in
India are reached in every corner of the country.
Stressing on the need for building a self-reliant
Innovation Ecosystem in the country, he stated, "India's journey towards
becoming a self-reliant nation rests on our ability to innovate within our own
borders. Through Medical Innovation
Patent Mitra, we are creating an environment where indigenous innovations in
the biomedical field are not only encouraged but effectively protected, paving
the way for a self-sustaining healthcare ecosystem." Dr Rajiv Bahl,
Director General, ICMR, highlighted that the initiative will bridge a crucial
gap in the patenting process for medical innovations, providing expert
assistance at every stage -- from patentability assessments to filing,
prosecution, and maintenance of patents...Amit
Agrawal, Secretary, Department of Pharmaceuticals (DoP), expressed his
enthusiasm about partnering with ICMR for this flagship initiative. He
emphasised that this initiative will greatly benefit innovators, start-ups, and
industries.These initiatives will complement the DoP's PRIP scheme,
contributing to the transformation of India's Pharma and MedTech sector from a
cost-driven model to one focused on innovation-based growth.
The Medical
Innovations Patent Mitra will support ICMR Institutes, ICMR Extramural Grantees
as well as medical colleges and institutes.It offers a comprehensive range of services, including patentability
assessment, patent filing in India, and assistance with patent prosecution.
The initiative also supports technology transfer,
providing handholding for the transfer of innovations to industry partners
through mechanisms like the Med Tech "Mela" and paperless Expression
of Interest (EoI) processes.